Vismodegib

Specifications

879085-55-9CAS Number

806-752-3EC Number

2-chloro-N-(4-chloro-3-pyridin-2-ylphenyl)-4-methylsulfonylbenzamideIUPAC Name

C19H14Cl2N2O3SChemical Formula

421.3 g/molMolecular Weight

Vismodegib; 879085-55-9; GDC-0449; Erivedge; 2-chloro-N-(4-chloro-3-(pyridin-2-yl)phenyl)-4-(methylsulfonyl)benzamide; HhAntag691; GDC0449; vismodegibum; NSC-747691; NSC 747691; NSC-755986; 2-chloro-N-(4-chloro-3-pyridin-2-ylphenyl)-4-methylsulfonylbenzamide; 25X868M3DS; RG-3616; 2-chloro-N-[4-chloro-3-(pyridin-2-yl)phenyl]-4-(methylsulfonyl)benzamide; CHEBI:66903; DTXSID40236689; R-3616; Benzamide, 2-chloro-N-(4-chloro-3-(2-pyridinyl)phenyl)-4-(methylsulfonyl)-; 2-CHLORO-N-(4-CHLORO-3-PYRIDIN-2-YL)PHENYL)-4-(METHYLSULFONYL)BENZAMIDE; RG3616; R3616 cpd; BENZAMIDE, 2-CHLORO-N-[4-CHLORO-3-(2-PYRIDINYL)PHENYL]-4-(METHYLSULFONYL)-; RefChem:58619; Hedgehog Antagonist GDC-0449; DTXCID20159180; L01XX43; Vismodegib (GDC-0449); GDC 0449; 2-Chloro-N-[4-chloro-3-(2-pyridinyl)phenyl]-4-(methylsulfonyl)benzamide; MFCD12407408; CHEMBL473417; NSC755986; s1082; 2-chloro-N-(4-chloro-3-pyridin-2-yl-phenyl)-4-methanesulfonyl-benzamide; 2-Chloranyl-~{n}-(4-Chloranyl-3-Pyridin-2-Yl-Phenyl)-4-Methylsulfonyl-Benzamide; Erivedge (TN); Vismodegib [USAN]; Vismodegib [USAN:INN]; C19H14Cl2N2O3S; UNII-25X868M3DS; HSDB 8130; R 3616; Benzamide, 2-chloro-N-[4-chloro-3-(2-pyridinyl)phenyl]-4-(methylsulfonyl)-; 2-Chloro-N-[4-chloro-3-(2-pyridinyl)phenyl]-4-(methylsulfonyl)benzamide; Erivedge; GDC 0449; Vismodegib; VIS; NSC747691; Hh-Antag691; HhAntag 691; Vismodegib, free base; methanesulfonylbenzamide; Vismodegib (Standard); VISMODEGIB [MI]; VISMODEGIB [INN]; Vismodegib (USAN/INN); VISMODEGIB [VANDF]; Vismodegib; GDC-0449; VISMODEGIB [WHO-DD]; MLS006012035; SCHEMBL302587; Vismodegib (GDC-0449)?; GTPL6975; orb1305292; SCHEMBL29352323; SCHEMBL29363748; SCHEMBL29394718; VISMODEGIB [ORANGE BOOK]; CUR-691; GDC-449; BPQMGSKTAYIVFO-UHFFFAOYSA-N; GLXC-02737; HMS3604K16; HMS3654E17; HMS5079E09; EX-A2178; 2-chloro-N-[4-chloro-3-(2-pyridyl)phenyl]-4-methylsulfonyl-benzamide; BDBM50249522; EBC-11415; HY-10440R; NSC755809; GDC-0449,Vismodegib, HhAntag691; 2-Chloro-N-(4-chloro-3-(pyridin-2-yl)-phenyl)-4-(methylsulfonyl)benzamide; 2-chloro-n-[4-chloro-3-(pyridin-2-yl)phenyl]-4-methanesulfonylbenzamide; AKOS015966534; CCG-264811; CS-0255; DB08828; FC28712; NSC-755809; PB15086; NCGC00242497-01; NCGC00242497-02; NCGC00242497-06; NCGC00242497-09; NCGC00242497-12; AC-26969; AS-14066; HY-10440; SMR004703564; G1408; NS00072471; SW218087-2; D09992; V-4050; AB01565813_02; EN300-7413185; SR-01000941574; 2-chloro-N-[4-chloro-3-(pyridin-2-yl)phenyl]-4-; Q2070286; SR-01000941574-1; BRD-K44827188-001-06-0; 2-Chloro-N-(4-chloro-3-(2-pyridl)phenyl)-4-(methylsulfonyl)benzamide; 2-chloro-N-(4-chloro-3-(pyridin-2-yl)phenyl)-4-(methyl sulfonyl)benzamide; 2-Chloro-N-[4-chloro-3-(pyridin-2-yl)phenyl]-4-(methanesulfonyl)benzamideSynonyms